Sophie Breunig

Sophie Breunig

Auto-generated profile, based on publicly available information

Sophie Breunig

Department of Psychology and Neuroscience, University of Colorado at Boulder, Boulder, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2023 in Nature Human Behaviour
Verified
Journal Article
Closed access
PDF file
Fiona Alysa HagenbeekFiona Alysa Hagenbeek
Fiona Alysa Hagenbeek
JHJana S. Hirzinger
Jana S. Hirzinger
SBSophie Breunig
Sophie Breunig
SBSusanne Bruins
Susanne Bruins
DKDmitry V. Kuznetsov
Dmitry V. Kuznetsov
DBDorret Irene Boomsma
Dorret Irene Boomsma

21 July 2025 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
SBSophie Breunig
Sophie Breunig
YLYounga Heather Lee
Younga Heather Lee
EKElizabeth W. Karlson
Elizabeth W. Karlson
AKArjun Krishnan
Arjun Krishnan
JLJeremy M. Lawrence
Jeremy M. Lawrence
AGAndrew D. Grotzinger
Andrew D. Grotzinger
Extant phenotypic and genetic literature has established consistent relationships between autoimmune, autoinflammatory, and psychiatric disorders. However, a comprehensive model investigating the association between a broad range of psychiatric disorders and immune-mediated disease in a multivariate framework is lacking. We utilized Genomic Structural Equation Modeling (Genomic SEM) to establish a factor structure across 11 immune-mediated diseases. Genetic correlations between these immune factors were examined with five established factors across 13 psychiatric disorders. We develop and validate a new heterogeneity metric, QFactor, that quantifies the degree to which factor correlations are driven by more specific pairwise associations, which were further investigated in the form of residual genetic correlations. A four-factor model of immune-mediated diseases fit the data well and described a continuum from autoimmune to autoinflammatory diseases, reflecting autoimmune, celiac, mixed pattern, and autoinflammatory diseases. Analyses revealed six significant factor correlations between the immune and psychiatric factors, including autoimmune and mixed pattern diseases with the substance use factors, autoinflammatory diseases and mixed pattern diseases with the internalizing factor, autoinflammatory diseases with the compulsive disorders factor, and autoinflammatory diseases with the schizophrenia/bipolar factor. Additionally, we find evidence of divergence in associations within factors as indicated by QFactor and 10 significant residual genetic correlations between individual psychiatric disorders and immune-mediated diseases. The results suggest that previously described relationships between specific psychiatric disorders and immune-mediated diseases often capture broader pathways of risk sharing indexed by our genomic factors yet are more specific than a general association across all psychiatric disorders and immune-mediated diseases.

13 March 2024 in Biological Psychiatry Global Open Science
Verified
Journal Article
Open access
SBSophie Breunig
Sophie Breunig
JLJeremy M. Lawrence
Jeremy M. Lawrence
IFIsabelle F. Foote
Isabelle F. Foote
HGHannah J. Gebhardt
Hannah J. Gebhardt
EWErik G. Willcutt
Erik G. Willcutt
AGAndrew D. Grotzinger
Andrew D. Grotzinger
Background Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder with diagnostic criteria requiring symptoms to begin in childhood. We investigated whether individuals diagnosed as children differ from those diagnosed in adulthood with respect to shared and unique architecture at the genome-wide and gene expression level of analysis. Methods We used genomic structural equation modeling (SEM) to investigate differences in genetic correlations (r(g)) of childhood-diagnosed (n(cases) = 14,878) and adulthood-diagnosed (n(cases) = 6961) ADHD with 98 behavioral, psychiatric, cognitive, and health outcomes. We went on to apply transcriptome-wide SEM to identify functional annotations and patterns of gene expression associated with genetic risk sharing or divergence across the ADHD subgroups. Results Compared with the childhood subgroup, adulthood-diagnosed ADHD exhibited a significantly larger negative r(g) with educational attainment, the noncognitive skills of educational attainment, and age at first sexual intercourse. We observed a larger positive r(g) for adulthood-diagnosed ADHD with major depression, suicidal ideation, and a latent internalizing factor. At the gene expression level, transcriptome-wide SEM analyses revealed 22 genes that were significantly associated with shared genetic risk across the subtypes that reflected a mixture of coding and noncoding genes and included 15 novel genes relative to the ADHD subgroups. Conclusions This study demonstrated that ADHD diagnosed later in life shows much stronger genetic overlap with internalizing disorders and related traits. This may indicate the potential clinical relevance of distinguishing these subgroups or increased misdiagnosis for those diagnosed later in life. Top transcriptome-wide SEM results implicated genes related to neuronal function and clinical characteristics (e.g., sleep).

19 July 2024 in medRxiv
Verified
Preprint
Open access
PDF file
SBSophie Breunig
Sophie Breunig
YLYounga Heather Lee
Younga Heather Lee
EKElizabeth W. Karlson
Elizabeth W. Karlson
AKArjun Krishnan
Arjun Krishnan
JLJeremy M. Lawrence
Jeremy M. Lawrence
AGAndrew D. Grotzinger
Andrew D. Grotzinger
Importance: Autoimmune and autoinflammatory diseases have been linked to psychiatric disorders in the phenotypic and genetic literature. However, a comprehensive model that investigates the association between a broad range of psychiatric disorders and immune-mediated disease in a multivariate framework is lacking. Objective: This study aims to establish a factor structure based on the genetic correlations of immune-mediated diseases and investigate their genetic relationships with clusters of psychiatric disorders. Design, Setting, and Participants: We utilized Genomic Structural Equation Modeling (Genomic SEM) to establish a factor structure of 11 immune-mediated diseases. Genetic correlations between these immune factors were examined with five established factors across 13 psychiatric disorders representing compulsive, schizophrenia/bipolar, neurodevelopmental, internalizing, and substance use disorders. We included GWAS summary statistics of individuals of European ancestry with sample sizes from 1,223 cases for Addison’s disease to 170,756 cases for major depressive disorder. Main Outcomes and Measures: Genetic correlations between psychiatric and immune-mediated disease factors and traits to determine genetic overlap. We develop and validate a new heterogeneity metric, Q Factor , that quantifies the degree to which factor correlations are driven by more specific pairwise associations. We also estimate residual genetic correlations between pairs of psychiatric disorders and immune-mediated diseases. Results: A four-factor model of immune-mediated diseases fit the data well and described a continuum from autoimmune to autoinflammatory diseases. The four factors reflected autoimmune, celiac, mixed pattern, and autoinflammatory diseases. Analyses revealed seven significant factor correlations between the immune and psychiatric factors, including autoimmune and mixed pattern diseases with the internalizing and substance use factors, and autoinflammatory diseases with the compulsive, schizophrenia/bipolar, and internalizing factors. Additionally, we find evidence of divergence in associations within factors as indicated by Q Factor . This is further supported by 14 significant residual genetic correlations between individual psychiatric disorders and immune-mediated diseases. Conclusion and Relevance: Our results revealed genetic links between clusters of immune-mediated diseases and psychiatric disorders. Current analyses indicate that previously described relationships between specific psychiatric disorders and immune-mediated diseases often capture broader pathways of risk sharing indexed by our genomic factors, yet are more specific than a general association across all psychiatric disorders and immune-mediated diseases. Key points: Question: How do immune-mediated diseases cluster together and how are they associated with clusters of psychiatric disorders? Findings: Immune-mediated diseases cluster into four factors along the overlapping spectrum of autoimmune to autoinflammatory diseases. There are seven significant factor correlations between immune-mediated disease factors and psychiatric disorders factors along with more specific pairwise associations between two disease traits. Meaning: Immune-mediated diseases are genetically associated with psychiatric disorders. While some associations seem to be driven by more general pathways, we also find that some of the shared signal is more specific to individual psychiatric-immune disease pairs.

21 February 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
JLJeremy M. Lawrence
Jeremy M. Lawrence
IFIsabelle F. Foote
Isabelle F. Foote
SBSophie Breunig
Sophie Breunig
LSLukas S. Schaffer
Lukas S. Schaffer
SLSiraj Lyons
Siraj Lyons
AGAndrew D. Grotzinger
Andrew D. Grotzinger
Epidemiological literature describes widespread psychiatric–physical comorbidity. However, the extent to which observed bivariate risk is transdiagnostic remains uncertain. We apply Genomic SEM and introduce Genomic E-SEM, an exploratory factor-analytic extension of Genomic SEM, here applied to 73 physical outcomes (~1.9 million cases) across eight medical domains. We then modeled latent physical illness factors alongside previously identified psychiatric factors. Thought/psychotic and compulsive factors exhibited few associations with physical illness factors. Conversely, internalizing, neurodevelopmental, and substance-use factors showed substantial genome-wide genetic correlations with all physical illness systems. Multivariate GWAS of a transdiagnostic physical illness factor, defined by 21 physical disorders, identified 27 genomic risk loci and exhibited substantial predictive validity in subsequent PheWAS. This transdiagnostic factor again exhibited substantial genome-wide genetic correlations with internalizing, neurodevelopmental, and substance-use factors. Our results reveal pervasive risk sharing between specific groups of psychiatric and physical conditions and suggest the need for additional nosological frameworks.

4 August 2024 in medRxiv
Verified
Preprint
Open access
PDF file
JLJeremy M. Lawrence
Jeremy M. Lawrence
IFIsabelle F. Foote
Isabelle F. Foote
SBSophie Breunig
Sophie Breunig
LSLukas S. Schaffer
Lukas S. Schaffer
TMTravis T. Mallard
Travis T. Mallard
AGAndrew D. Grotzinger
Andrew D. Grotzinger
Epidemiological literature has shown that there are extensive comorbidity patterns between psychiatric and physical illness. However, our understanding of the multivariate systems of relationships underlying these patterns is poorly understood. Using Genomic SEM and Genomic E-SEM, an extension for genomic exploratory factor analysis that we introduce and validate, we evaluate the extent to which latent genomic factors from eight domains, encompassing 76 physical outcomes across 1.9 million cases, evince genetic overlap with previously identified psychiatric factors. We find that internalizing, neurodevelopmental, and substance use factors are broadly associated with increased genetic risk sharing across all physical illness domains. Conversely, we find that a compulsive factor is protective against circulatory and metabolic illness, whereas genetic risk sharing between physical illness factors and psychotic/thought disorders was limited. Our results reveal pervasive risk sharing between specific groups of psychiatric and physical conditions and call into question the bifurcation of psychiatric and physical conditions.